Nelson J - Search Results

1

CSR1 suppresses tumor growth and metastasis of prostate cancer.

Yu G, Tseng GC, Yu YP, Gavel T, Nelson J, Wells A, Michalopoulos G, Kokkinakis D, Luo JH. Yu G, et al. Among authors: nelson j. Am J Pathol. 2006 Feb;168(2):597-607. doi: 10.2353/ajpath.2006.050620. Am J Pathol. 2006. PMID: 16436673 Free PMC article.

2

Gene expression alterations in prostate cancer predicting tumor aggression and preceding development of malignancy.

Yu YP, Landsittel D, Jing L, Nelson J, Ren B, Liu L, McDonald C, Thomas R, Dhir R, Finkelstein S, Michalopoulos G, Becich M, Luo JH. Yu YP, et al. Among authors: nelson j. J Clin Oncol. 2004 Jul 15;22(14):2790-9. doi: 10.1200/JCO.2004.05.158. J Clin Oncol. 2004. PMID: 15254046

3

High throughput screening of methylation status of genes in prostate cancer using an oligonucleotide methylation array.

Yu YP, Paranjpe S, Nelson J, Finkelstein S, Ren B, Kokkinakis D, Michalopoulos G, Luo JH. Yu YP, et al. Among authors: nelson j. Carcinogenesis. 2005 Feb;26(2):471-9. doi: 10.1093/carcin/bgh310. Epub 2004 Oct 14. Carcinogenesis. 2005. PMID: 15485992

4

Endothelin-1 inhibits apoptosis in prostate cancer.

Nelson JB, Udan MS, Guruli G, Pflug BR. Nelson JB, et al. Neoplasia. 2005 Jul;7(7):631-7. doi: 10.1593/neo.04787. Neoplasia. 2005. PMID: 16026642 Free PMC article.

5

MCM7 amplification and overexpression are associated with prostate cancer progression.

Ren B, Yu G, Tseng GC, Cieply K, Gavel T, Nelson J, Michalopoulos G, Yu YP, Luo JH. Ren B, et al. Among authors: nelson j. Oncogene. 2006 Feb 16;25(7):1090-8. doi: 10.1038/sj.onc.1209134. Oncogene. 2006. PMID: 16247466

6

Analysis of integrin alpha7 mutations in prostate cancer, liver cancer, glioblastoma multiforme, and leiomyosarcoma.

Ren B, Yu YP, Tseng GC, Wu C, Chen K, Rao UN, Nelson J, Michalopoulos GK, Luo JH. Ren B, et al. Among authors: nelson j. J Natl Cancer Inst. 2007 Jun 6;99(11):868-80. doi: 10.1093/jnci/djk199. J Natl Cancer Inst. 2007. PMID: 17551147

7

Glutathione peroxidase 3, deleted or methylated in prostate cancer, suppresses prostate cancer growth and metastasis.

Yu YP, Yu G, Tseng G, Cieply K, Nelson J, Defrances M, Zarnegar R, Michalopoulos G, Luo JH. Yu YP, et al. Among authors: nelson j. Cancer Res. 2007 Sep 1;67(17):8043-50. doi: 10.1158/0008-5472.CAN-07-0648. Cancer Res. 2007. PMID: 17804715

8

CSR1 induces cell death through inactivation of CPSF3.

Zhu ZH, Yu YP, Shi YK, Nelson JB, Luo JH. Zhu ZH, et al. Among authors: nelson jb. Oncogene. 2009 Jan 8;28(1):41-51. doi: 10.1038/onc.2008.359. Epub 2008 Sep 22. Oncogene. 2009. PMID: 18806823 Free PMC article.

9

MCM7 interacts with androgen receptor.

Shi YK, Yu YP, Zhu ZH, Han YC, Ren B, Nelson JB, Luo JH. Shi YK, et al. Am J Pathol. 2008 Dec;173(6):1758-67. doi: 10.2353/ajpath.2008.080363. Epub 2008 Nov 6. Am J Pathol. 2008. PMID: 18988800 Free PMC article.

10

Investigating Multi-cancer Biomarkers and Their Cross-predictability in the Expression Profiles of Multiple Cancer Types.

Tseng GC, Cheng C, Yu YP, Nelson J, Michalopoulos G, Luo JH. Tseng GC, et al. Among authors: nelson j. Biomark Insights. 2009 May 1;4:57-79. doi: 10.4137/bmi.s930. Biomark Insights. 2009. PMID: 19652763 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

7,012 results

Search Page